{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:51:36Z","timestamp":1782478296572,"version":"3.54.5"},"reference-count":103,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.idc.2019.08.007","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T06:29:24Z","timestamp":1571984964000},"page":"1125-1141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Invasive Pneumococcal and Meningococcal Disease"],"prefix":"10.1016","volume":"33","author":[{"given":"Deirdre","family":"Fitzgerald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant W.","family":"Waterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.idc.2019.08.007_bib1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. adults","volume":"373","author":"Jain","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.idc.2019.08.007_bib2","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1086\/374624","article-title":"Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential","volume":"187","author":"Brueggemann","year":"2003","journal-title":"J\u00a0Infect Dis"},{"issue":"52","key":"10.1016\/j.idc.2019.08.007_bib3","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.1016\/j.vaccine.2018.10.098","article-title":"Serotypes and genotypes of S.\u00a0pneumoniae isolates from adult invasive disease in Spain: a 5-year prospective surveillance after pediatric PCV13 licensure. The ODIN study","volume":"36","author":"Fenoll","year":"2018","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.idc.2019.08.007_bib4","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1016\/j.vaccine.2011.02.088","article-title":"Healthcare utilization and cost of pneumococcal disease in the United States","volume":"29","author":"Huang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.idc.2019.08.007_bib5","series-title":"Immunization, vaccines and biologicals","author":"World Health Organisation","year":"2013"},{"issue":"39\u201340","key":"10.1016\/j.idc.2019.08.007_bib6","doi-asserted-by":"crossref","first-page":"6837","DOI":"10.1016\/j.vaccine.2007.07.039","article-title":"Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong","volume":"25","author":"Ho","year":"2007","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.idc.2019.08.007_bib7","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2019.08.007_bib8","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1365-3156.2006.01697.x","article-title":"Invasive pneumococcal disease in children <5 years of age in rural Mozambique","volume":"11","author":"Roca","year":"2006","journal-title":"Trop Med Int Health"},{"issue":"9","key":"10.1016\/j.idc.2019.08.007_bib9","doi-asserted-by":"crossref","first-page":"e1001517","DOI":"10.1371\/journal.pmed.1001517","article-title":"Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites","volume":"10","author":"Feikin","year":"2013","journal-title":"PLoS Med"},{"issue":"16","key":"10.1016\/j.idc.2019.08.007_bib10","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","article-title":"Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine","volume":"294","author":"Lexau","year":"2005","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.idc.2019.08.007_bib11","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-0001","article-title":"Immunization, antibiotic use, and pneumococcal colonization over a 15-year period","volume":"140","author":"Lee","year":"2017","journal-title":"Pediatrics"},{"issue":"25\u201326","key":"10.1016\/j.idc.2019.08.007_bib12","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1016\/j.vaccine.2004.02.038","article-title":"Serotype distribution and antimicrobial resistance patterns of nasopharyngeal and invasive Streptococcus pneumoniae isolates in Hong Kong children","volume":"22","author":"Ho","year":"2004","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.idc.2019.08.007_bib13","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1086\/381686","article-title":"Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae","volume":"189","author":"Sandgren","year":"2004","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2019.08.007_bib14","doi-asserted-by":"crossref","first-page":"e0169368","DOI":"10.1371\/journal.pone.0169368","article-title":"Effectiveness of the 23-valent Pneumococcal Polysaccharide Vaccine (PPV23) against pneumococcal disease in the elderly: systematic review and meta-analysis","volume":"12","author":"Falkenhorst","year":"2017","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.idc.2019.08.007_bib15","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJM199111213252101","article-title":"The protective efficacy of polyvalent pneumococcal polysaccharide vaccine","volume":"325","author":"Shapiro","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.idc.2019.08.007_bib16","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3201\/eid1907.121830","article-title":"Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1.)","volume":"19","author":"Richter","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"18","key":"10.1016\/j.idc.2019.08.007_bib17","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.idc.2019.08.007_bib18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa0800836","article-title":"Effect of pneumococcal conjugate vaccine on pneumococcal meningitis","volume":"360","author":"Hsu","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.idc.2019.08.007_bib19","first-page":"629","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2019.08.007_bib20","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.vaccine.2017.11.085","article-title":"Invasive pneumococcal disease in children under 16 years of age: incomplete rebound in incidence after the maximum effect of PCV13 in 2012\/13 in Germany","volume":"36","author":"Weinberger","year":"2018","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.idc.2019.08.007_bib21","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1473-3099(14)70822-9","article-title":"Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study","volume":"14","author":"Andrews","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2019.08.007_bib22","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"31","key":"10.1016\/j.idc.2019.08.007_bib23","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1016\/j.vaccine.2018.06.018","article-title":"Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010-2016","volume":"36","author":"Demczuk","year":"2018","journal-title":"Vaccine"},{"issue":"50","key":"10.1016\/j.idc.2019.08.007_bib24","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1016\/j.vaccine.2016.10.062","article-title":"Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era","volume":"34","author":"Wiese","year":"2016","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.idc.2019.08.007_bib25","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.idc.2019.08.007_bib26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"45","key":"10.1016\/j.idc.2019.08.007_bib27","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.1016\/j.vaccine.2018.02.113","article-title":"Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants","volume":"36","author":"Greenberg","year":"2018","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.idc.2019.08.007_bib28","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1086\/381197","article-title":"High-level penicillin-nonsusceptible Streptococcus pneumoniae bacteremia: identification of a low-risk subgroup","volume":"38","author":"Ruhe","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2019.08.007_bib29","author":"CDC"},{"issue":"6","key":"10.1016\/j.idc.2019.08.007_bib30","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1086\/514783","article-title":"Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study","volume":"28","author":"Song","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2019.08.007_bib31","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJMoa0903029","article-title":"A\u00a0trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults","volume":"362","author":"French","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.idc.2019.08.007_bib32","doi-asserted-by":"crossref","first-page":"100 e1","DOI":"10.1016\/j.amjmed.2017.06.039","article-title":"Effect of age on the manifestations and outcomes of invasive pneumococcal disease in adults","volume":"131","author":"Marrie","year":"2018","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.idc.2019.08.007_bib33","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s12879-018-3326-z","article-title":"Clinical and economic burden of pneumococcal disease in US adults aged 19-64 years with chronic or immunocompromising diseases: an observational database study","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"20","key":"10.1016\/j.idc.2019.08.007_bib34","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1056\/NEJMoa044113","article-title":"Asthma as a risk factor for invasive pneumococcal disease","volume":"352","author":"Talbot","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.idc.2019.08.007_bib35","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1097\/INF.0000000000001989","article-title":"Preterm children have higher risk than full-term children of invasive pneumococcal disease during the first 2 years of life","volume":"37","author":"Riise","year":"2018","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.idc.2019.08.007_bib36","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM200003093421002","article-title":"Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team","volume":"342","author":"Nuorti","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.idc.2019.08.007_bib37","doi-asserted-by":"crossref","first-page":"396","DOI":"10.7326\/M17-1907","article-title":"Opioid analgesic use and risk for invasive pneumococcal diseases: a nested case-control study","volume":"168","author":"Wiese","year":"2018","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.idc.2019.08.007_bib38","first-page":"422","article-title":"Impact of vaccination on invasive pneumococcal disease in adults with focus on the immunosuppressed","volume":"71","author":"Sangil","year":"2015","journal-title":"J\u00a0Infect"},{"issue":"2","key":"10.1016\/j.idc.2019.08.007_bib39","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/cid\/ciu274","article-title":"Invasive pneumococcal disease in children can reveal a primary immunodeficiency","volume":"59","author":"Gaschignard","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"39","key":"10.1016\/j.idc.2019.08.007_bib40","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1016\/j.vaccine.2018.07.039","article-title":"The effect of immunosuppressive agents on immunogenicity of pneumococcal vaccination: a systematic review and meta-analysis","volume":"36","author":"van Aalst","year":"2018","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.idc.2019.08.007_bib41","doi-asserted-by":"crossref","first-page":"314","DOI":"10.7326\/0003-4819-117-4-314","article-title":"Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives","volume":"117","author":"Janoff","year":"1992","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.idc.2019.08.007_bib42","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1183\/09031936.00056813","article-title":"Pneumococcal disease seasonality: incidence, severity and the role of influenza activity","volume":"43","author":"Weinberger","year":"2014","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.idc.2019.08.007_bib43","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/368163","article-title":"Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae","volume":"187","author":"McCullers","year":"2003","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2019.08.007_bib44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1017\/S0950268804003085","article-title":"PspA family typing and PCR-based DNA fingerprinting with BOX A1R primer of pneumococci from the blood of patients in the USA with and without sickle cell disease","volume":"133","author":"Payne","year":"2005","journal-title":"Epidemiol Infect"},{"issue":"9","key":"10.1016\/j.idc.2019.08.007_bib45","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1086\/425368","article-title":"Practice guidelines for the management of bacterial meningitis","volume":"39","author":"Tunkel","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2019.08.007_bib46","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1097\/01.CCM.0000239434.26669.65","article-title":"Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study","volume":"34","author":"Auburtin","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.idc.2019.08.007_bib47","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s12879-016-1711-z","article-title":"Time to antibiotic therapy and outcome in bacterial meningitis: a Danish population-based cohort study","volume":"16","author":"Bodilsen","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2019.08.007_bib48","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1128\/JCM.01480-08","article-title":"Diagnosis of Streptococcus pneumoniae infections in adults with bacteremia and community-acquired pneumonia: clinical comparison of pneumococcal PCR and urinary antigen detection","volume":"47","author":"Smith","year":"2009","journal-title":"J\u00a0Clin Microbiol"},{"issue":"7","key":"10.1016\/j.idc.2019.08.007_bib49","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1128\/JCM.42.7.2919-2925.2004","article-title":"Prospective study of a real-time PCR that is highly sensitive, specific, and clinically useful for diagnosis of meningococcal disease in children","volume":"42","author":"Bryant","year":"2004","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.idc.2019.08.007_bib50","doi-asserted-by":"crossref","first-page":"j2471","DOI":"10.1136\/bmj.j2471","article-title":"Advances in the causes and management of community acquired pneumonia in adults","volume":"358","author":"Wunderink","year":"2017","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.idc.2019.08.007_bib51","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1001\/jamainternmed.2014.4887","article-title":"beta-Lactam monotherapy vs beta-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial","volume":"174","author":"Garin","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"14","key":"10.1016\/j.idc.2019.08.007_bib52","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJMoa1406330","article-title":"Antibiotic treatment strategies for community-acquired pneumonia in adults","volume":"372","author":"Postma","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.idc.2019.08.007_bib53","first-page":"405","article-title":"The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults","volume":"72","author":"McGill","year":"2016","journal-title":"J\u00a0Infect"},{"issue":"8","key":"10.1016\/j.idc.2019.08.007_bib54","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/adc.2008.151563","article-title":"Short versus long duration of antibiotic therapy for bacterial meningitis: a meta-analysis of randomised controlled trials in children","volume":"94","author":"Karageorgopoulos","year":"2009","journal-title":"Arch Dis Child"},{"issue":"17","key":"10.1016\/j.idc.2019.08.007_bib55","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1212\/WNL.0b013e3181f96297","article-title":"Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis","volume":"75","author":"Brouwer","year":"2010","journal-title":"Neurology"},{"issue":"20","key":"10.1016\/j.idc.2019.08.007_bib56","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJMoa021334","article-title":"Dexamethasone in adults with bacterial meningitis","volume":"347","author":"de Gans","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.idc.2019.08.007_bib57","article-title":"Corticosteroids for acute bacterial meningitis","author":"Brouwer","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.idc.2019.08.007_bib58","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/MCP.0000000000000155","article-title":"Improving outcomes from community-acquired pneumonia","volume":"21","author":"Waterer","year":"2015","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.idc.2019.08.007_bib59","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejcdt.2013.03.009","article-title":"Adjuvant role of corticosteroids in the treatment of community-acquired pneumonia","volume":"62","author":"Nafae","year":"2013","journal-title":"Egypt J Chest Dis Tuberc"},{"issue":"3","key":"10.1016\/j.idc.2019.08.007_bib60","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/rccm.200406-808OC","article-title":"Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study","volume":"171","author":"Confalonieri","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.idc.2019.08.007_bib61","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.2015.88","article-title":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial","volume":"313","author":"Torres","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2019.08.007_bib62","doi-asserted-by":"crossref","first-page":"j1415","DOI":"10.1136\/bmj.j1415","article-title":"Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study","volume":"357","author":"Waljee","year":"2017","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.idc.2019.08.007_bib63","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.idc.2019.08.007_bib64","doi-asserted-by":"crossref","first-page":"e0147877","DOI":"10.1371\/journal.pone.0147877","article-title":"Host factors and biomarkers associated with poor outcomes in adults with invasive pneumococcal disease","volume":"11","author":"Hanada","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.idc.2019.08.007_bib65","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.amjmed.2010.11.014","article-title":"Incidence of cardiovascular events after hospital admission for pneumonia","volume":"124","author":"Perry","year":"2011","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.idc.2019.08.007_bib66","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1086\/518849","article-title":"The association between pneumococcal pneumonia and acute cardiac events","volume":"45","author":"Musher","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2019.08.007_bib67","doi-asserted-by":"crossref","first-page":"e1004383","DOI":"10.1371\/journal.ppat.1004383","article-title":"Streptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac function","volume":"10","author":"Brown","year":"2014","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.idc.2019.08.007_bib68","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/MCA.0b013e32835d7610","article-title":"Does aspirin use prevent acute coronary syndrome in patients with pneumonia: multicenter prospective randomized trial","volume":"24","author":"Oz","year":"2013","journal-title":"Coron Artery Dis"},{"issue":"18","key":"10.1016\/j.idc.2019.08.007_bib69","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJMoa040845","article-title":"Clinical features and prognostic factors in adults with bacterial meningitis","volume":"351","author":"van de Beek","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.idc.2019.08.007_bib70","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/jnnp.2006.110023","article-title":"Cognitive outcome in adults after bacterial meningitis","volume":"78","author":"Hoogman","year":"2007","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.idc.2019.08.007_bib71","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/649209","article-title":"Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease","volume":"50","author":"Cohn","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2019.08.007_bib72","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1073\/pnas.94.1.271","article-title":"Capsule switching of Neisseria meningitidis","volume":"94","author":"Swartley","year":"1997","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"2","key":"10.1016\/j.idc.2019.08.007_bib73","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1128\/jcm.32.2.323-330.1994","article-title":"Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population","volume":"32","author":"Caugant","year":"1994","journal-title":"J\u00a0Clin Microbiol"},{"issue":"17\u201318","key":"10.1016\/j.idc.2019.08.007_bib74","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.vaccine.2005.01.063","article-title":"MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain","volume":"23","author":"Oster","year":"2005","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.idc.2019.08.007_bib75","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1128\/JCM.42.11.5146-5153.2004","article-title":"Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway","volume":"42","author":"Yazdankhah","year":"2004","journal-title":"J\u00a0Clin Microbiol"},{"issue":"8","key":"10.1016\/j.idc.2019.08.007_bib76","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3201\/eid0808.010422","article-title":"Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000","volume":"8","author":"Aguilera","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2019.08.007_bib77","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.ebiom.2015.09.007","article-title":"Genomic epidemiology of hypervirulent serogroup W, ST-11 Neisseria meningitidis","volume":"2","author":"Mustapha","year":"2015","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.idc.2019.08.007_bib78","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1086\/315158","article-title":"The changing epidemiology of meningococcal disease in the United States, 1992-1996","volume":"180","author":"Rosenstein","year":"1999","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2019.08.007_bib79","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1371\/journal.pmed.0040101","article-title":"Clonal waves of Neisseria colonisation and disease in the African meningitis belt: eight- year longitudinal study in northern Ghana","volume":"4","author":"Leimkugel","year":"2007","journal-title":"PLoS Med"},{"issue":"10","key":"10.1016\/j.idc.2019.08.007_bib80","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/jama.1990.03450100061026","article-title":"Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis","volume":"264","author":"Moore","year":"1990","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.idc.2019.08.007_bib81","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1473-3099(04)01251-4","article-title":"Meningococcal polysaccharide-protein conjugate vaccines","volume":"5","author":"Snape","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"9251","key":"10.1016\/j.idc.2019.08.007_bib82","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(00)03594-7","article-title":"Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England","volume":"357","author":"Ramsay","year":"2001","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.idc.2019.08.007_bib83","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/jama.2012.85","article-title":"Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial","volume":"307","author":"Gossger","year":"2012","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.idc.2019.08.007_bib84","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/jac\/46.5.717","article-title":"Subinhibitory concentrations of erythromycin reduce pneumococcal adherence to respiratory epithelial cells in\u00a0vitro","volume":"46","author":"Lagrou","year":"2000","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.idc.2019.08.007_bib85","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1473-3099(14)70806-0","article-title":"Epidemiology of invasive meningococcal disease in the Netherlands, 1960-2012: an analysis of national surveillance data","volume":"14","author":"Bijlsma","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"9911","key":"10.1016\/j.idc.2019.08.007_bib86","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(13)61612-8","article-title":"Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected]","volume":"383","author":"Daugla","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.idc.2019.08.007_bib87","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1651-2227.2000.tb00360.x","article-title":"Neisseria meningitidis: evolution of penicillin resistance and phenotype in a children's hospital in Barcelona, Spain","volume":"89","author":"Latorre","year":"2000","journal-title":"Acta Paediatr"},{"issue":"1","key":"10.1016\/j.idc.2019.08.007_bib88","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/jac\/dkw400","article-title":"Emergence of meningococci with reduced susceptibility to third-generation cephalosporins","volume":"72","author":"Deghmane","year":"2017","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.idc.2019.08.007_bib89","doi-asserted-by":"crossref","first-page":"e1001838","DOI":"10.1371\/journal.pmed.1001838","article-title":"Shifts in the antibiotic susceptibility, serogroups, and clonal complexes of Neisseria meningitidis in Shanghai, China: a time trend analysis of the Pre-Quinolone and Quinolone Eras","volume":"12","author":"Chen","year":"2015","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.idc.2019.08.007_bib90","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/sextrans-2016-052781","article-title":"Genomic analysis of urogenital and rectal Neisseria meningitidis isolates reveals encapsulated hyperinvasive meningococci and coincident multidrug-resistant gonococci","volume":"93","author":"Harrison","year":"2017","journal-title":"Sex Transm Infect"},{"issue":"4","key":"10.1016\/j.idc.2019.08.007_bib91","first-page":"367","article-title":"Observations on the meningococcus carrier-rate in relation to density of population in sleeping quarters","volume":"17","author":"Glover","year":"1918","journal-title":"J\u00a0Hyg (Lond)"},{"issue":"6","key":"10.1016\/j.idc.2019.08.007_bib92","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1001\/jama.286.6.688","article-title":"Risk factors for meningococcal disease in college students","volume":"286","author":"Bruce","year":"2001","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.idc.2019.08.007_bib93","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/00006454-199710000-00015","article-title":"Tobacco smoke as a risk factor for meningococcal disease","volume":"16","author":"Fischer","year":"1997","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.idc.2019.08.007_bib94","doi-asserted-by":"crossref","first-page":"e0158524","DOI":"10.1371\/journal.pone.0158524","article-title":"A\u00a0case-control study on the risk factors for meningococcal disease among children in Greece","volume":"11","author":"Hadjichristodoulou","year":"2016","journal-title":"PLoS One"},{"issue":"7159","key":"10.1016\/j.idc.2019.08.007_bib95","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/bmj.317.7159.621","article-title":"Which contacts of patients with meningococcal disease carry the pathogenic strain of Neisseria meningitidis? A population based study","volume":"317","author":"Kristiansen","year":"1998","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.idc.2019.08.007_bib96","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/cid\/cix438","article-title":"Increased risk for meningococcal disease among men who have sex with men in the United States, 2012-2015","volume":"65","author":"Folaranmi","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2019.08.007_bib97","first-page":"57","article-title":"Complement deficiencies and meningococcal disease","volume":"86","author":"Densen","year":"1991","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1016\/j.idc.2019.08.007_bib98","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1097\/QAD.0b013e32833a2520","article-title":"Increased incidence of meningococcal disease in HIV-infected individuals associated with higher case-fatality ratios in South Africa","volume":"24","author":"Cohen","year":"2010","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.idc.2019.08.007_bib99","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/cid\/ciy141","article-title":"A\u00a0registry for patients with asplenia\/hyposplenism reduces the risk of infections with encapsulated organisms","volume":"67","author":"Arnott","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"8665","key":"10.1016\/j.idc.2019.08.007_bib100","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(89)90781-2","article-title":"Effect of smoking on meningococcal carriage","volume":"2","author":"Stuart","year":"1989","journal-title":"Lancet"},{"issue":"9508","key":"10.1016\/j.idc.2019.08.007_bib101","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(06)67932-4","article-title":"Clinical recognition of meningococcal disease in children and adolescents","volume":"367","author":"Thompson","year":"2006","journal-title":"Lancet"},{"issue":"7452","key":"10.1016\/j.idc.2019.08.007_bib102","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1136\/bmj.328.7452.1339","article-title":"Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review","volume":"328","author":"Purcell","year":"2004","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.idc.2019.08.007_bib103","doi-asserted-by":"crossref","first-page":"ofz059","DOI":"10.1093\/ofid\/ofz059","article-title":"Invasive meningococcal disease: what we should know, before it comes back","volume":"6","author":"Cabellos","year":"2019","journal-title":"Open Forum Infect Dis"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552019300662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552019300662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:13:52Z","timestamp":1760195632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552019300662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":103,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0891552019300662"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2019.08.007","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invasive Pneumococcal and Meningococcal Disease","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2019.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}